Szegedi A - Search Results

1

Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.

Szegedi A, Wetzel H, Leal M, Härtter S, Hiemke C. Szegedi A, et al. J Clin Psychiatry. 1996 Jun;57(6):257-64. J Clin Psychiatry. 1996. PMID: 8666564 Clinical Trial.

2

Minimum effective dose for antidepressants--an obligatory requirement for antidepressant drug evaluation?

Benkert O, Szegedi A, Wetzel H. Benkert O, et al. Among authors: szegedi a. Int Clin Psychopharmacol. 1996 Sep;11(3):177-85. doi: 10.1097/00004850-199609000-00004. Int Clin Psychopharmacol. 1996. PMID: 8923096 Review.

3

Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.

Wetzel H, Anghelescu I, Szegedi A, Wiesner J, Weigmann H, Härter S, Hiemke C. Wetzel H, et al. Among authors: szegedi a. J Clin Psychopharmacol. 1998 Feb;18(1):2-9. doi: 10.1097/00004714-199802000-00002. J Clin Psychopharmacol. 1998. PMID: 9472836 Clinical Trial.

4

Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial.

Anghelescu I, Szegedi A, Schlegel S, Weigmann H, Hiemke C, Wetzel H. Anghelescu I, et al. Among authors: szegedi a. Eur Neuropsychopharmacol. 1998 Dec;8(4):315-20. doi: 10.1016/s0924-977x(97)00093-x. Eur Neuropsychopharmacol. 1998. PMID: 9928923 Clinical Trial.

5

Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial.

Szegedi A, Anghelescu I, Wiesner J, Schlegel S, Weigmann H, Härtter S, Hiemke C, Wetzel H. Szegedi A, et al. Pharmacopsychiatry. 1999 Jul;32(4):148-53. doi: 10.1055/s-2007-979221. Pharmacopsychiatry. 1999. PMID: 10505485 Clinical Trial.

6

Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.

Wetzel H, Szegedi A, Scheurich A, Lörch B, Singer P, Schläfke D, Sittinger H, Wobrock T, Müller MJ, Anghelescu I, Hautzinger M; NeVeR Study Group. Wetzel H, et al. Among authors: szegedi a. J Clin Psychiatry. 2004 Oct;65(10):1406-13. doi: 10.4088/jcp.v65n1017. J Clin Psychiatry. 2004. PMID: 15491246 Clinical Trial.

7

Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine.

Szegedi A, Wiesner J, Hiemke C. Szegedi A, et al. J Clin Psychopharmacol. 1995 Apr;15(2):141-3. doi: 10.1097/00004714-199504000-00012. J Clin Psychopharmacol. 1995. PMID: 7782489 No abstract available.

8

Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.

Benkert O, Wetzel H, Szegedi A. Benkert O, et al. Among authors: szegedi a. Int Clin Psychopharmacol. 1993 Sep;8 Suppl 1:3-14. Int Clin Psychopharmacol. 1993. PMID: 8254151 Review. No abstract available.

9

Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response.

Benkert O, Szegedi A, Wetzel H, Staab HJ, Meister W, Philipp M. Benkert O, et al. Among authors: szegedi a. Acta Psychiatr Scand. 1997 Apr;95(4):288-96. doi: 10.1111/j.1600-0447.1997.tb09634.x. Acta Psychiatr Scand. 1997. PMID: 9150822 Clinical Trial.

10

A double-blind study comparing paroxetine and maprotiline in depressed outpatients.

Szegedi A, Wetzel H, Angersbach D, Dunbar GC, Schwarze H, Philipp M, Benkert O. Szegedi A, et al. Pharmacopsychiatry. 1997 May;30(3):97-105. doi: 10.1055/s-2007-979490. Pharmacopsychiatry. 1997. PMID: 9211571 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters